CTNM - Contineum Therapeutics Inc. - Ordinary Shares - Class A
IEX Last Trade
19.42
0.510 2.626%
Share volume: 43,782
Last Updated: Fri 30 Aug 2024 09:56:41 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.91
0.51
2.70%
Summary score
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CTNM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 17.45% | 19.89% | 4.69% |
| Return on assets | 0% | 3.37% | 11.41% | 3.35% |
| Return on sales | 0% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | 0% | 5.2% | -272.99% | 4.37% |
| Profitability | 0% | 69% | 75% | 50% |
| Total debt ratio | 0% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | 0% | 0.36% | -1.16% | 10.77% |
| Dept financing | 0% | 26% | 18% | 44% |
| Current Ratio | 0% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 0% | 0.17% | 0.31% | 0.53% |
| Liquididy | 0% | 54% | 47% | 75% |
| Short-term ratios | CTNM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 44.06% | 17.3% | 6.24% |
| Return on assets | 0% | 3.88% | 9.33% | 3.22% |
| Return on sales | 0% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | 0% | 9.69% | -224.06% | 4.96% |
| Profitability | 0% | 77% | 60% | 41% |
| Total debt ratio | 0% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | 0% | 8.35% | -0.88% | 10.36% |
| Dept financing | 0% | 45% | 15% | 42% |
| Current Ratio | 0% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 0% | 0.17% | 0.31% | 0.53% |
| Liquididy | 0% | 53% | 54% | 75% |